Charles River Laboratories International Inc (NYSE:CRL)
$ 219 -2.48 (-1.12%) Market Cap: 11.28 Bil Enterprise Value: 14.03 Bil PE Ratio: 25.70 PB Ratio: 3.10 GF Score: 96/100

Charles River Laboratories International Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 03:00PM GMT
Release Date Price: $268.24 (-2.92%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

Okay. Good morning. We're going to kick it off. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this morning, Charles River Labs. For those that have questions, please submit through the website.

And with that, I'll turn it over to Jim.

James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President

Thanks, Tycho. It's always a pleasure to be at JPMorgan, albeit virtually this year. So I would point you to our safe harbor statement, Reg G statement. And of course, we are in a quiet period. So we've had a lot of first and some significant milestones in the company. We worked on more than 80% of the drugs that were approved over the last 3 years. We've doubled the revenue of the company over the last 5. We're working at about a $15 billion market. So it gives us a lot of leeway and runway to grow our business in the current markets that we're in. We have a market leadership position in many of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot